RGCC test

From RationalWiki
Jump to: navigation, search
Against allopathy
Alternative medicine
Icon alt med alt.svg
Clinically unproven

The RGCC blood-test, also known as "the Greek test" or "the Greece test", is a blood-test purportedly to determine which chemotherapy agent would be most effective in a person with cancer, i.e. a chemosensitivity test.Wikipedia's W.svg The name is the forced acronym "Research Genetic Cancer Centre"[1], any resemblance to the RGCC geneWikipedia's W.svg responsible for controlling the rate of cell-division is of course purely coincidental.

Patently untrue[edit]

The RGCC test is only carried out in Greece, however the blood they purportedly test is not just Greek: 25mL samples from across the world[2] are sent there to be analysed. The inventor of the RGCC test is Dr. Ioannis Papasotiriou[3], who reportedly holds a patent on the process.[4] However, a patent-search for his name only gives one result: a 'patent-application' for a proposed cancer-treatment,[5] which is not a patent for a test.

Daily speed-limit[edit]

RGCC claim to generate "trillions" of cells from less than 200 cells, in less than 36 hours.
RGCC International network of (sales) representatives & clinics.
Picture of the RGCC USA team.

The American agent for RGCC, a chiropractor named Dr Ray Hammon[6], states that their chemosensitivity test involves extracting the "5-200" circulating tumour cells (CTCs) from the 25mL of blood submitted, and culturing those approximately 100 cells up to a population of "trillions" in "just 24-36 hours".[7] Finding the "5-200" needles in the haystack that is a 25mL blood sample, would be very difficult, but not impossible. Whereas producing "trillions" of cancer cells from approximately 100 cells in "just 24-36 hours" is impossible. Dozens of cancer cell-lines are known, their 'typical doubling-time is approximately daily',[8] i.e. the number of cells doubles every 24 hours: if you started with 100 cells, after 1 day you'd have 200 cells, after 2 days 400, after 3 days 800, et cetera. It would take 34 days to reach a "trillion" cells. (In 2013 a laboratory grew a few cow-muscle cells into a beef-burger: the quarter-pounder only contained about 1/10th of a trillion cells, but took three months to grow in the lab[9] and cost over $300K).

Notably, a blood test will not detect tumor cells unless it is a blood-borne cancer (generally leukemia or lymphoma), or the cancer has metastasized into the blood from its original organ.

The RGCC chemosensitivity test allegedly evaluates the efficacy of so-called "natural substances", as well as pharmaceutical chemotherapy agents. According to RGCC the category of "natural substances" includes these patent-medicines:

  • Aromat8-PN™
  • Artecin®
  • Bio-D-Mulsion®
  • NuMedica Micellized D3®
  • Meriva®
  • Intenzyme Forte™
  • Mammary PMG®
  • Nrf2 Activator™
  • Retenzyme Forte®
  • Salicinium™
  • Thymex®
  • Virxcan™

That the test specifies those patent-medicines explains why the RGCC test is only used by integrative-practitioners; they are the only group who would offer those unproven treatments.

As no laboratory could culture sufficient tumor cells to perform the 100+ tests within the turnaround time, the results of the RGCC chemosensitivity test could just be a form-letter[12] recommending to the integrative-practitioner that they prescribe whatever pills they have a surfeit of.

As of 2016, costs for the RGCC chemosensitivity tests range from $1824 to $3126.[13]

External links[edit]